Literature DB >> 26392936

DOT, S, or DOTS?

Armand Van Deun1, Hans L Rieder1.   

Abstract

Year:  2012        PMID： 26392936      PMCID： PMC4536561          DOI： 10.5588/pha.12.0007

Source DB:  PubMed          Journal:  Public Health Action        ISSN： 2220-8372


× No keyword cloud information.
  8 in total

Review 1.  Treatment of tuberculosis and optimal dosing schedules.

Authors:  Kwok Chiu Chang; Chi Chiu Leung; Jacques Grosset; Wing Wai Yew
Journal:  Thorax       Date:  2010-12-17       Impact factor: 9.139

2.  Turning liabilities into resources: informal village doctors and tuberculosis control in Bangladesh.

Authors:  M A Hamid Salim; Mukund Uplekar; Paul Daru; Maug Aung; E Declercq; Knut Lönnroth
Journal:  Bull World Health Organ       Date:  2006-06-21       Impact factor: 9.408

3.  Directly observed therapy and treatment adherence.

Authors:  J Volmink; P Matchaba; P Garner
Journal:  Lancet       Date:  2000-04-15       Impact factor: 79.321

4.  Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan.

Authors:  J D Walley; M A Khan; J N Newell; M H Khan
Journal:  Lancet       Date:  2001-03-03       Impact factor: 79.321

5.  [Field experiences with 6-month therapy in the treatment of open pulmonary tuberculosis in a refugee camp].

Authors:  H Rieder
Journal:  Prax Klin Pneumol       Date:  1983-10

6.  Drug resistance monitoring: combined rates may be the best indicator of programme performance.

Authors:  A Van Deun; A H Salim; P Daru; A P K Das; K J M Aung; Md A Hossain; L Rigouts; K Fissette; F Portaels
Journal:  Int J Tuberc Lung Dis       Date:  2004-01       Impact factor: 2.373

7.  The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis.

Authors:  S E Weis; P C Slocum; F X Blais; B King; M Nunn; G B Matney; E Gomez; B H Foresman
Journal:  N Engl J Med       Date:  1994-04-28       Impact factor: 91.245

8.  Does directly observed therapy (DOT) reduce drug resistant tuberculosis?

Authors:  Patrick K Moonan; Teresa N Quitugua; Janice M Pogoda; Gary Woo; Gerry Drewyer; Behzad Sahbazian; Denise Dunbar; Kenneth C Jost; Charles Wallace; Stephen E Weis
Journal:  BMC Public Health       Date:  2011-01-07       Impact factor: 3.295
  8 in total
  4 in total

1.  Clinical profile and treatment outcomes of drug-resistant tuberculosis before directly observed treatment strategy plus: Lessons for the program.

Authors:  Yatin N Dholakia; Divya P Shah
Journal:  Lung India       Date:  2013-10

2.  Bridging the gap between policy and practice: a qualitative analysis of providers' field experiences tinkering with directly observed therapy in patients with drug-resistant tuberculosis in Addis Ababa, Ethiopia.

Authors:  Kirubel Manyazewal Mussie; Christoph Gradmann; Tsegahun Manyazewal
Journal:  BMJ Open       Date:  2020-06-16       Impact factor: 2.692

3.  Home-Based and Facility-Based Directly Observed Therapy of Tuberculosis Treatment under Programmatic Conditions in Urban Tanzania.

Authors:  Francis Mhimbira; Jerry Hella; Thomas Maroa; Shadrack Kisandu; Magreth Chiryamkubi; Khadija Said; Grace Mhalu; Abdallah Mkopi; Beatrice Mutayoba; Klaus Reither; Sébastien Gagneux; Lukas Fenner
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

Review 4.  An Ayurvedic personalized prophylactic protocol in COVID-19.

Authors:  Pratibha P Nair; Parvathy G Nair; K M Pratap Shankar
Journal:  J Ayurveda Integr Med       Date:  2020-09-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.